• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, October 4, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Clodagh O’Shea receives Allen Distinguished Investigator award to study genome

Bioengineer by Bioengineer
October 30, 2018
in Biology
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Salk Institute

LA JOLLA–(October 30, 2018) Clodagh O'Shea, a professor in Salk's Molecular and Cell Biology Laboratory and a Howard Hughes Medical Institute Faculty Scholar, has been selected as a recipient of The Paul G. Allen Frontiers Group's Allen Distinguished Investigator (ADI) program. She will be awarded $1.5 million over three years to conduct research into how DNA and its associated proteins (known collectively as chromatin) are packaged in the nucleus of cells. The work has implications for better understanding not only a range of diseases but also the fundamentals of human biology.

"Clodagh's research into chromatin is causing biologists to rethink a longstanding paradigm about how the genome is organized," says Salk President Rusty Gage. "Her development of a powerful new technology to visualize chromatin's 3D structure in living cells launches what promises to be a revolutionary new way to understand DNA. We are thrilled to have her exciting and groundbreaking work supported by The Paul G. Allen Frontiers Group."

Human DNA in a single cell is about 6 feet long and is wrapped around proteins into flexible and intricate polymer packages–chromatin–that enable it to be compacted into the cell nucleus (.001 mm). Although the human genome has been decoded, the chromatin structure and 3D organization of our DNA and genes in nuclear space and time is still a mystery. Increasingly, scientists have strived to understand this packaging and how individual genes are accessed or stored away (silenced) in the cell nucleus. These processes are implicated in everything from healthy development to fighting off disease.

O'Shea, who holds the Wicklow Capital Chair at Salk, is developing novel techniques to visualize the structure and function of chromatin in time and space. One innovation is ChromEM, which exploits a DNA dye that can be activated with light to undergo a complex series of chemical reactions that "paints" the surface of DNA with a metal. By combining ChromEM staining with an advanced form of electron microscopy tomography developed by Mark Ellisman's lab at UC San Diego (UCSD), the chromatin structure and 3D interactions of DNA can be reconstructed in intact cells and tissues.

O'Shea will lead an interdisciplinary team of researchers at Salk and UCSD to test a new theory that, at critical concentrations in the nucleus, chromatin polymers change states between liquids and gels to determine gene activity and ultimately cell fate. When chromatin is dilute, it behaves like a liquid, enabling genes to be accessed and read. However, when chromatin exceeds a critical concentration threshold, chromatin chains form entangled gels that limit access to genes. O'Shea's team will determine if this simple biophysical principle underpins gene expression changes in normal and disease states. This new research frontier could reveal critical clues and groundbreaking therapies for preventing, diagnosing and treating diseases, such as cancer, premature aging and viral infection.

###

The Allen Distinguished Investigator program began in 2010 to fund early-stage research that is less likely to receive support from traditional funding sources, but which has the potential to significantly advance our understanding of biology. Including the 9 awards given to 10 investigators in 2018, there have been 69 Allen Distinguished Investigators appointed since 2010.

About the Salk Institute for Biological Studies:

Every cure has a starting point. The Salk Institute embodies Jonas Salk's mission to dare to make dreams into reality. Its internationally renowned and award-winning scientists explore the very foundations of life, seeking new understandings in neuroscience, genetics, immunology, plant biology and more. The Institute is an independent nonprofit organization and architectural landmark: small by choice, intimate by nature and fearless in the face of any challenge. Be it cancer or Alzheimer's, aging or diabetes, Salk is where cures begin. Learn more at: salk.edu.

Media Contact

Salk Communications
[email protected]
858-453-4100
@salkinstitute

http://www.salk.edu

Original Source

https://www.salk.edu/news-release/clodagh-oshea-receives-allen-distinguished-investigator-award-to-study-genome/

Share12Tweet8Share2ShareShareShare2

Related Posts

DOG Gene Family in Wheat Drives Seed Dormancy

DOG Gene Family in Wheat Drives Seed Dormancy

October 4, 2025
blank

Discovery of MrSTP20: Sugar Transporter in Salt Stress

October 4, 2025

SNARE Neofunctionalization Driven by Vacuole Retrieval

October 4, 2025

Exploring Shigella Phage Sf14’s tRNA Contributions

October 3, 2025
Please login to join discussion

POPULAR NEWS

  • New Study Reveals the Science Behind Exercise and Weight Loss

    New Study Reveals the Science Behind Exercise and Weight Loss

    93 shares
    Share 37 Tweet 23
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    90 shares
    Share 36 Tweet 23
  • Physicists Develop Visible Time Crystal for the First Time

    75 shares
    Share 30 Tweet 19
  • New Insights Suggest ALS May Be an Autoimmune Disease

    69 shares
    Share 28 Tweet 17

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Vasopressin vs Epinephrine: Pediatric Cardiac Arrest Outcomes

α-L-Fucosidase Isoenzymes: New Glioma Prognostic Markers

Inflammatory Markers Shape EGFR-Mutant Lung Cancer

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 62 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.